ArticleEcancermedicalscience2020

Is there a role for rechallenge and reintroduction of anti-EGFR plus chemotherapy in later lines of therapy for metastatic colorectal carcinoma? A retrospective analysis.

Amanda Karani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.